Found 72 matching trials
Safety and Toleration of PEP005 Topical Gel When Applied to a Treatment Area of up to 100cm2 PHASE1 Study Hypothesis: Safety and Tolerability will differ when treating multipl...
Show More Learn More & Join Trial
Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Nodular Basal Cell Carcinoma PHASE2 The purpose of this study is to determine whether topical application of PE...
Show More Location
Southderm Pty Ltd
Learn More & Join Trial
The Purpose of This Study is to Determine Whether Topical Application of PEP005 is Safe for the Treatment of Common Wart(s) PHASE1 Verruca vulgaris, otherwise known as the common wart, is caused by the huma...
Show More Location
South East Dermatology, 1202 Creek Rd
Learn More & Join Trial
Ingenol Mebutate (Picato®) With Methyl Aminolevulinate Photodynamic Therapy for the Treatment of Actinic Keratosis PHASE2 The objective of this study is to determine the efficacy, safety, and patie...
Show More Location
Multiple Locations
Learn More & Join Trial
Study to Evaluate the Safety and Efficacy of PEP005 (Ingenol Mebutate) Gel, 0.015%, in Patients With Photo-damaged Skin PHASE2 This study is primarily designed to evaluate the safety and tolerability of...
Show More Learn More & Join Trial
Efficacy and Safety of Ingenol Mebutate Gel 0.06% When Applied Once Daily for 2, 3 or 4 Consecutive Days to a Treatment Area of Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic Keratosis PHASE2 This is a randomised, double-blind, parallel groups, vehicle controlled, 8-...
Show More Location
Long Island Skin Cancer and Dermatologic Surgery
Learn More & Join Trial
Efficacy and Safety of Ingenol Mebutate Gel for Actinic Keratosis Applied on Large Area on Face, Scalp or Chest PHASE3 The objective of the trial is to investigate efficacy and safety of ingenol...
Show More Location
Laser & Skin Surgery Center of Indiana
Learn More & Join Trial
To Determine the Maximum Tolerated Dose Level (MTD) of PEP005 Topical Gel in Patients With sBCC PHASE2 The purpose of this study is to determine maximum tolerated dose level (MTD...
Show More Learn More & Join Trial
A Multi-center Study to Evaluate the Safety and Efficacy of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on Non-head Locations (Trunk and Extremities) PHASE3 The open label study is designed to assess the safety and efficacy of 0.05%...
Show More Location
Park Avenue Dermatology
Learn More & Join Trial
Picato for the Treatment of Molluscum Contagiosum in Immunocompromised Patients EARLY_PHASE1 Patients at least 18 years of age will be enrolled in the study to assess t...
Show More Location
Center for Clinical Studies
Learn More & Join Trial